Lipoarabinomannan point-of-care tests: evaluation with fresh samples needed

Lancet Infect Dis. 2019 Oct;19(10):1053. doi: 10.1016/S1473-3099(19)30475-X.

Authors

John T Connelly¹, Benjamin Grant², Vanisha Munsamy³, Alexander Pym³, Akos Somoskovi⁴

Affiliations

¹ Intellectual Ventures Laboratory, Bellevue, WA 98007, USA. Electronic address: jconnelly@intven.com.
² Intellectual Ventures Laboratory, Bellevue, WA 98007, USA.
³ African Health Research Institute, KwaZulu-Natal, South Africa.
⁴ Intellectual Ventures' Global Good Fund, Bellevue, WA, USA.

PMID: 31559954
DOI: 10.1016/S1473-3099(19)30475-X

No abstract available

Publication types

Letter
Comment

MeSH terms

HIV Infections*
Humans
Lipopolysaccharides
Point-of-Care Systems
Tuberculosis*

Substances

Lipopolysaccharides
lipoarabinomannan